/JYNT
JYNT Stock - The Joint Corp.
Healthcare|Medical - Care FacilitiesNASDAQ
$9.00+1.81%
+$0.16 (+1.81%) • Dec 19
70
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.46
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).100
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.68
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+122.2%upside
Target: $20.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for JYNT
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$8.91 – $9.09
TARGET (TP)$20.00
STOP LOSS$8.28
RISK/REWARD1:15.3
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.30
52W High$13.47
52W Low$7.50
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $52.16M | $46.98M | $101.25M | $80.01M | $58.68M |
| Gross Profit | $40.65M | $36.50M | $92.08M | $72.35M | $52.18M |
| Gross Margin | 77.9% | 77.7% | 90.9% | 90.4% | 88.9% |
| Operating Income | $-1,889,025 | $318,299 | $828,254 | $6.13M | $5.49M |
| Net Income | $-5,796,893 | $-9,752,197 | $626,705 | $7.57M | $13.17M |
| Net Margin | -11.1% | -20.8% | 0.6% | 9.5% | 22.4% |
| EPS | $-0.57 | $-0.66 | $0.04 | $0.46 | $0.94 |
Company Overview
The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics. The company operates in two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and regional developers. As of March 1, 2022, the company operated approximately 700 locations in the United States. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
2
29%
Hold / Neutral
4
57%
Sell / Underperform
1
14%
Analyst Consensus🔴 Bearish
2 Bullish5 Neutral/Bearish
Price Targets
$22
Average Target
↑ 148.1% Upside
Now
$9
Low
$22
Average
$36
High
Based on 6 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| September 19th 2023 | Craig Hallum | Resumed | Hold | $9 |
| August 11th 2023 | Maxim Group | Downgrade | Hold | - |
| March 13th 2023 | DA Davidson | Upgrade | Neutral | $15← $12 |
| August 5th 2022 | B. Riley Securities | Upgrade | Buy | $31 |
| August 5th 2022 | Maxim Group | Upgrade | Buy | $36 |
| May 9th 2022 | DA Davidson | Downgrade | Underperform | $13← $69 |
| May 6th 2022 | Craig Hallum | Downgrade | Hold | $30← $90 |
Earnings History & Surprises
JYNTBeat Rate
47%
Last 17 quarters
Avg Surprise
+690.8%
EPS vs Estimate
Beats / Misses
8/8
1 met exactly
Latest EPS
$0.02
Q4 2025
EPS Surprise History
Q1 24
+6350.0%
$0.07vs$-0.00
Q2 24
+1100.0%
$0.06vs$0.01
Q3 24
-629.9%
$-0.06vs$-0.01
Q4 24
+2731.6%
$0.04vs$-0.00
Q1 25
0.0%
$0.06vs$0.06
Q2 25
-50.0%
$-0.03vs$-0.02
Q3 25
+14.3%
$-0.06vs$-0.07
Q4 25
+300.0%
$0.02vs$-0.01
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 6, 2026 | — | — | — | — |
Q1 2026 | Mar 12, 2026 | $0.05 | — | — | — |
Q4 2025 | Nov 6, 2025 | $-0.01 | $0.02 | +300.0% | ✓ BEAT |
Q3 2025 | Aug 7, 2025 | $-0.07 | $-0.06 | +14.3% | ✓ BEAT |
Q2 2025 | May 8, 2025 | $-0.02 | $-0.03 | -50.0% | ✗ MISS |
Q1 2025 | Mar 13, 2025 | $0.06 | $0.06 | 0.0% | = MET |
Q4 2024 | Nov 7, 2024 | $-0.00 | $0.04 | +2731.6% | ✓ BEAT |
Q3 2024 | Aug 8, 2024 | $-0.01 | $-0.06 | -629.9% | ✗ MISS |
Q2 2024 | May 2, 2024 | $0.01 | $0.06 | +1100.0% | ✓ BEAT |
Q1 2024 | Mar 7, 2024 | $-0.00 | $0.07 | +6350.0% | ✓ BEAT |
Q4 2023 | Nov 9, 2023 | $-0.01 | $-0.05 | -377.6% | ✗ MISS |
Q3 2023 | Sep 13, 2023 | $-0.00 | $-0.01 | -200.3% | ✗ MISS |
Q2 2023 | May 4, 2023 | $0.01 | $0.15 | +2597.8% | ✓ BEAT |
Q1 2023 | Mar 9, 2023 | $0.08 | $0.04 | -50.0% | ✗ MISS |
Q4 2022 | Nov 3, 2022 | $0.05 | $0.03 | -40.0% | ✗ MISS |
Q3 2022 | Aug 4, 2022 | $0.01 | $0.02 | +50.0% | ✓ BEAT |
Q2 2022 | May 5, 2022 | $-0.00 | $-0.01 | -124.2% | ✗ MISS |
Q1 2022 | Feb 24, 2022 | $0.08 | $0.01 | -87.5% | ✗ MISS |
Q4 2021 | Nov 4, 2021 | — | $0.21 | — | — |
Q4 2021 | Nov 4, 2021 | $0.05 | $0.13 | +160.0% | ✓ BEAT |
Latest News
The Joint Corp. Signs $1.5M APA To Sell 22 Clinics, Buyers Assume Operations Mid‑December; Terminates Prior 45‑Clinic Southern California Deal
➖ NeutralBenzinga•Dec 11, 2025, 09:55 PM
Joint Q3 EPS $0.06 Beats $0.05 Estimate, Sales $13.381M Beat $13.360M Estimate
📈 PositiveBenzinga•Nov 6, 2025, 09:29 PM
The Joint Corp. Board Authorizes Additional $12M For Stock Repurchase Program
📈 PositiveBenzinga•Nov 5, 2025, 12:26 PM
The Joint sells 36 clinics in strategic refranchising, expansion deals; shares up
📈 PositiveSeeking Alpha•Jun 25, 2025, 12:58 PM
Frequently Asked Questions about JYNT
What is JYNT's current stock price?
The Joint Corp. (JYNT) is currently trading at $9.00 per share. The stock has moved +1.81% today.
What is the analyst price target for JYNT?
The average analyst price target for JYNT is $20.00, based on 1 analyst.
What sector is The Joint Corp. in?
The Joint Corp. operates in the Healthcare sector, specifically within the Medical - Care Facilities industry. The company is traded on the NASDAQ exchange.
What is JYNT's market cap?
The Joint Corp. has a market capitalization of $0.14 billion, making it a small-cap company.
Does JYNT pay dividends?
No, The Joint Corp. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAPYX
Apyx Medical Corporation
$3.49
Mkt Cap: $0.1B
BTMD
biote Corp.
$2.78
Mkt Cap: $0.1B
CCLD
CareCloud, Inc.
$3.21
Mkt Cap: $0.1B
CGTX
Cognition Therapeutics, Inc.
$1.54
Mkt Cap: $0.1B
DCGO
DocGo Inc.
$0.89
Mkt Cap: $0.1B
IKT
Inhibikase Therapeutics, Inc.
$1.72
Mkt Cap: $0.1B
LUCD
Lucid Diagnostics Inc.
$1.12
Mkt Cap: $0.1B
RPID
Rapid Micro Biosystems, Inc.
$3.15
Mkt Cap: $0.1B
SERA
Sera Prognostics, Inc.
$3.55
Mkt Cap: $0.1B
STSS
Sharps Technology, Inc.
$2.22
Mkt Cap: $0.1B
Explore stocks similar to JYNT for comparison